[HTML][HTML] Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity
Q Zheng, J Tang, A Aicher, T Bou Kheir… - Journal of Experimental …, 2023 - Springer
Background Pancreatic ductal adenocarcinoma (PDAC) is a profoundly aggressive and fatal
cancer. One of the key factors defining its aggressiveness and resilience against …
cancer. One of the key factors defining its aggressiveness and resilience against …
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity
Q Zheng, J Tang, A Aicher, T Bou Kheir… - … OF EXPERIMENTAL & …, 2023 - iris.univr.it
Background: Pancreatic ductal adenocarcinoma (PDAC) is a profoundly aggressive and
fatal cancer. One of the key factors defining its aggressiveness and resilience against …
fatal cancer. One of the key factors defining its aggressiveness and resilience against …
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
Q Zheng, J Tang, A Aicher, B Sabanovic… - … of Experimental & …, 2023 - europepmc.org
Background Pancreatic ductal adenocarcinoma (PDAC) is a profoundly aggressive and fatal
cancer. One of the key factors defining its aggressiveness and resilience against …
cancer. One of the key factors defining its aggressiveness and resilience against …
[HTML][HTML] Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity
Q Zheng, J Tang, A Aicher, TB Kheir… - … of Experimental & …, 2023 - ncbi.nlm.nih.gov
Background Pancreatic ductal adenocarcinoma (PDAC) is a profoundly aggressive and fatal
cancer. One of the key factors defining its aggressiveness and resilience against …
cancer. One of the key factors defining its aggressiveness and resilience against …
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity
Q Zheng, J Tang, A Aicher, TB Kheir… - … of Experimental and …, 2023 - search.proquest.com
Background Pancreatic ductal adenocarcinoma (PDAC) is a profoundly aggressive and fatal
cancer. One of the key factors defining its aggressiveness and resilience against …
cancer. One of the key factors defining its aggressiveness and resilience against …
[HTML][HTML] Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity
Q Zheng, J Tang, A Aicher… - … of Experimental & …, 2023 - jeccr.biomedcentral.com
Pancreatic ductal adenocarcinoma (PDAC) is a profoundly aggressive and fatal cancer. One
of the key factors defining its aggressiveness and resilience against chemotherapy is the …
of the key factors defining its aggressiveness and resilience against chemotherapy is the …
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
Q Zheng, J Tang, A Aicher… - … of Experimental & …, 2023 - search.ebscohost.com
Background: Pancreatic ductal adenocarcinoma (PDAC) is a profoundly aggressive and
fatal cancer. One of the key factors defining its aggressiveness and resilience against …
fatal cancer. One of the key factors defining its aggressiveness and resilience against …
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity
Q Zheng, J Tang, A Aicher, TB Kheir… - … of experimental & …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Pancreatic ductal adenocarcinoma (PDAC) is a profoundly aggressive and fatal
cancer. One of the key factors defining its aggressiveness and resilience against …
cancer. One of the key factors defining its aggressiveness and resilience against …
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity
Q Zheng, J Tang, A Aicher, T Bou Kheir, B Sabanovic… - 2023 - digital.csic.es
[Results]: Our findings demonstrate that NR5A2 plays a dual role in PDAC. In differentiated
cancer cells, NR5A2 promotes cell proliferation by inhibiting CDKN1A. On the other hand, in …
cancer cells, NR5A2 promotes cell proliferation by inhibiting CDKN1A. On the other hand, in …
[PDF][PDF] Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity
Q Zheng, J Tang, A Aicher, TB Kheir, B Sabanovic… - 2023 - jeccr.biomedcentral.com
Background Pancreatic ductal adenocarcinoma (PDAC) is a profoundly aggressive and fatal
cancer. One of the key factors defining its aggressiveness and resilience against …
cancer. One of the key factors defining its aggressiveness and resilience against …